The market is expected to see a 3.7 percent compound annual growth rate during the forecast period. This growth can be attributed to an increasing prevalence of certain medical conditions and the need for early detection and diagnosis, according to a Feb. 23 release.
The market was most recently valued at $279.65 billion in 2022, up from $271.41 billion in 2021.
